Clinical Trials Logo

Type 2 Diabetes clinical trials

View clinical trials related to Type 2 Diabetes.

Filter by:

NCT ID: NCT01360567 Completed - Type 2 Diabetes Clinical Trials

The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia

Start date: May 2011
Phase: Phase 3
Study type: Interventional

The aim of the study is to examine whether the extract of green tea is effective on type 2 diabetes and hyperlipidemia.

NCT ID: NCT01357304 Completed - Hypertension Clinical Trials

10 Prescriptions an Hour. Group Treatment and Physical Activity Referral in a Primary Health Care Setting

10PAR
Start date: March 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of group treatment including physical activity referral (PAR) on level of physical activity and quality of life in patients diagnosed with type 2 diabetes and/or hypertension in a primary health care setting

NCT ID: NCT01356953 Completed - Type 2 Diabetes Clinical Trials

Exercise Intensity and Type 2 Diabetics

EIT2D
Start date: October 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if a single session of aerobic exercise effectively controls the blood pressure (BP) of individuals with type 2 diabetes mellitus (T2DM) over the 24h of post-exercise period, and the effects of intensity of aerobic exercise on these BP responses.

NCT ID: NCT01353391 Completed - Type 2 Diabetes Clinical Trials

Metformin in Women With Type 2 Diabetes in Pregnancy Trial

MiTy
Start date: May 25, 2011
Phase: Phase 3
Study type: Interventional

Insulin is the standard treatment for the management of type 2 diabetes in pregnancy, however despite treatment with insulin, these women continue to face increased rates of adverse maternal and fetal outcomes. The investigators hypothesize that metformin use, in addition to treatment with insulin, will help with blood sugar control, lower the dose of insulin needed, lower weight gain, and improve baby outcomes.

NCT ID: NCT01353118 Completed - Type 2 Diabetes Clinical Trials

The Effects of Glycemic Optimization Before Gastric Bypass Surgery

GLUCOSURG2
Start date: May 2011
Phase: N/A
Study type: Interventional

Metabolic surgery such as gastric bypass, gastric banding or sleeve gastrectomy operations can cause rapid and uncontrolled reductions in blood glucose. There is limited information on whether: - metabolic surgery is superior to modern medical care for glycaemic control and type 2 diabetes remission. - metabolic surgery is safe for microvascular complications of Type 2 diabetes - good glycaemic control pre surgery has any effects on the long term glycaemia and complications of type 2 diabetes. This study aims to assess: 1. whether metabolic surgery is better for diabetes control compared to medical treatment. 2. whether metabolic surgery is safe for eye, nerve and kidney complications. 3. whether good sugar control before metabolic surgery improves the long term effects of sugar control and microvascular complications.

NCT ID: NCT01349387 Completed - Type 2 Diabetes Clinical Trials

Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing

METFORGENE
Start date: May 2011
Phase: N/A
Study type: Interventional

Main objective : Show that treatment with metformin in patients with type 2 diabetes has an effect on alternative splicing of the insulin receptor. Secondary objective : demonstrate that the effect on the ratio A/isoform B isoform with discontinuation of treatment with metformin can be réversé by the resumption of metformin treatment.

NCT ID: NCT01349374 Terminated - Type 2 Diabetes Clinical Trials

Skin Samples of Diabetic Patients and Healthy Volunteers Collection

Start date: January 2011
Phase: N/A
Study type: Interventional

The main objective of this study is the Obtention of skin micro-samples collected from healthy volunteers and diabetic patients (type 2 and MODY), intended to be used afterwards to obtain stem cell lines, in the framework of new therapeutic strategies of type 2 diabetes.

NCT ID: NCT01349166 Active, not recruiting - Type 2 Diabetes Clinical Trials

Effects of 3 Months of Supervised Exercise Training

Start date: February 2008
Phase: N/A
Study type: Interventional

The incidence of type 2 diabetes is increasing worldwide. Because of cardiovascular morbidity and mortality associated with type 2 diabetes, it is imperative to propose methods of prevention and this in early stage of abnormal glucose metabolism. This study will assess the beneficial effects of physical activity (acute and chronic effects) (the subjects being their own controls) on cardiometabolic and inflammatory biomarkers in 3 conditions : unstimulated (fasting and resting conditions) and stimulated conditions: postprandial response to a standardized meal preceded or not by an exercise bout. The investigators hypothesized that an acute bout of exercise will decrease the postprandial inflammatory response to a standardized meal and that this effect of exercise will be increased after 3 months of exercise training.

NCT ID: NCT01348568 Completed - Type 2 Diabetes Clinical Trials

Low Glycemic Index Diet (With Canola Oil) for Type 2 Diabetics

Start date: March 2011
Phase: Phase 2
Study type: Interventional

Healthy individuals with type 2 diabetes will receive intensive counseling on food selection to improve glucose control using either high cereal fiber dietary strategies or low glycemic index foods especially canola oil containing bread. The treatments will last 3 months with bloods taken for HbA1c, glucose and blood lipids. If the study shows a benefit for either or both diets, then use of high fiber, and/or low glycemic index foods with canola oil, may provide another potential way to improve glucose control and lower cholesterol levels in non-insulin dependent diabetes.

NCT ID: NCT01346527 Completed - Type 2 Diabetes Clinical Trials

Fat Metabolism in Pregnancy and Neonatal Heart Function in Diabetes

Start date: April 2011
Phase:
Study type: Observational

Background: The health of the next generation is likely programmed in the womb (i.e.in utero), and our understanding of how that programming happens will allow us to favorably influence the health of future generations. The focus of this proposal is to examine the effect of in utero programming on heart function in children born to women with type 2 diabetes (T2DM). Specifically, neonates born to diabetic women have abnormal heart structure and weaker heart function at birth, which may predispose them to long-term heart problems in childhood, adolescence and adulthood. At present, the reason for these heart abnormalities in children born to women with diabetes is unknown and is the focus of this proposal. Objective(s) and Hypothesis(es): The objectives are to examine the relationships among maternal lipid (fatty acid, triglyceride, very low density lipoprotein) metabolism and neonatal heart structure and function in diabetes and to identify clinical markers during pregnancy for heart dysfunction in infants born to diabetic women. The overall hypothesis is that maternal lipid metabolism is abnormal in diabetes, and this metabolic dysregulation increases fatty acid delivery to the fetus in utero and leads to abnormal accumulation of lipid in the fetal heart, resulting in altered neonatal heart structure and function in infants born to diabetic women. In addition, the investigators hypothesize that decreased maternal fatty acid oxidation (fat "burning") rate, elevated lipolytic (fat breakdown) rate and elevated blood total free fatty acid level predicts abnormal neonatal heart structure and function in infants born to women with type 2 diabetes. Methods and Procedures: The investigators will test these hypotheses by using clinical metabolism studies (infusion of stable isotope labeled fatty acid, serial blood and breath sampling, and mass spectrometry) to quantify whole-body fat (fatty acid oxidation, lipolysis, and serum fatty acid , triglycerides, VLDL-cholesterol levels) metabolism in 25 diabetic women during the 3rd trimester of pregnancy, and compare these lipid metabolism kinetics to 25 body mass index matched healthy non-diabetic women during pregnancy and determine if alterations in maternal lipid metabolism predict abnormal neonatal heart function in children born to these women. Potential Impact: Type 2 diabetes is an epidemic in the United States and is steadily increasing worldwide. Diabetes has detrimental health effects in pregnant women and in their offspring. The investigators know that children born to women with diabetes have an increased risk for developing diabetes, obesity and cardiovascular disease, than children born to healthy women. This proposal will address an important knowledge gap regarding the role of maternal lipid (and potentially other nutrients) metabolism on the cardiovascular health of the global and increasing population of children born to diabetic women. Findings from this project will be novel and innovative, and will likely point to clinical interventions that target and correct lipid and other metabolic abnormalities in women with pre-gestational diabetes. The impact will be great because the long-term goal is to ameliorate heart problems in children born to diabetic (both pre-gestational and gestational) women. In addition, this project will establish a small cohort of children that can be followed long-term to address novel questions about the progression of heart and other metabolic abnormalities in children born to diabetic women.